- What the results of current studies with enzalutamide say - a commentary on the studies2021 | Publication without faculty affiliation
- Darolutamide in the treatment of metastatic castrate-resistant prostate cancer2022 | First Faculty of Medicine
- Effectiveness and safety of abiraterone acetate treatment for metastatic castration-resistant prostate cancer post-chemotherapy2018 | First Faculty of Medicine
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine